News

Search EMA's news announcements

Резултати (3799)

Preliminary data indicate COVID-19 vaccines remain effective against severe disease and hospitalisation caused by the Omicron variant

11 January 2022

NewsHumanCOVID-19Vaccines

EMA receives application for conditional marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19

10 January 2022

NewsHumanCOVID-19Medicines

Emer Cooke’s end-of-year message

22 December 2021

NewsCorporateCOVID-19

EMA recommends Nuvaxovid for authorisation in the EU

20 December 2021

NewsHumanCOVID-19Vaccines

EMA working on COVID-19 over holiday period

20 December 2021

NewsHumanCorporateCOVID-19

EMA Management Board: highlights of December 2021 meeting

17 December 2021

NewsCorporate

New treatment for sickle cell disease

17 December 2021

NewsHumanMedicines

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 December 2021

17 December 2021

NewsHumanCOVID-19Medicines

EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19: rolling review starts in parallel

16 December 2021

NewsHumanCOVID-19Medicines

Increase in manufacturing capacity for COVID-19 vaccines from Janssen, Moderna and BioNTech/Pfizer

16 December 2021

NewsHumanCOVID-19Vaccines